RHT's India deal raises questions
Its board should be asked to provide more clarity about the transaction which merits greater scrutiny by unitholders
IT WAS probably good news to unitholders when Religare Health Trust (RHT) announced its proposed acquisition of a clinical facility known as Mohali Clinical Establishment in Punjab, India, signalling further room for growth. What isn't so favourable is that it will soon have to vote on other transactions linked to this deal, even as some questions are left unanswered.
In a regulatory filing on Feb 2, RHT said it had agreed to acquire Mohali Clinical Establishment from Radha Soami Satsang Beas (RSSB) for $55.1 million.
It also agreed to enter into separate agreements, which are interested person transactions (IPTs), with its sponsor Fortis Healthcare for the purchase of related equipment and services.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Air China to buy 100 locally made C919 jets in US$11 billion deal
HCA beats first-quarter profit estimates on higher patient admissions
F&B operator YKGI to exclusively operate Chicha San Chen in Macau for next eight years
LMIRT Q1 net property income dips 3.1% to S$30 million on higher expenses
Exxon misses on Q1 profit despite big gains in Guyana
US FDA approves Pfizer’s gene therapy for rare bleeding disorder